Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sanders

Showing results (901-910 of 915) with videos related to

Pageof 92
Sort By:
Immunity|June 22, 2017
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized ApproachesMatthias Pauthner, Colin Havenar-Daughton, Devin Sok, et al.
Science Immunology|August 30, 2024
Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaquesAshley N Nelson, Xiaoying Shen, Sravani Vekatayogi, et al.
Nature Communications|June 3, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody responseKenta Matsuda, Mitra Harrison, Eleanor Wettstein, et al.
Science Translational Medicine|May 12, 2021
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophagesWillianne Hoepel, Hung-Jen Chen, Chiara E Geyer, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Nature|March 5, 2014
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesNicole A Doria-Rose, Chaim A Schramm, Jason Gorman, et al.
Nature Communications|October 21, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsPauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Nature Communications|November 21, 2025
HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trialEmma I M M Reiss, Karlijn van der Straten, Laura T M Graus, et al.
Cell|February 12, 2021
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionPhilip J M Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2022
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunityLeanne P M van Leeuwen, Corine H GeurtsvanKessel, Pauline M Ellerbroek, et al.
Pageof 92

Showing results (901-910 of 915) with videos related to

Sort By:
Pageof 92
Immunity|June 22, 2017
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized ApproachesMatthias Pauthner, Colin Havenar-Daughton, Devin Sok, et al.
Science Immunology|August 30, 2024
Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaquesAshley N Nelson, Xiaoying Shen, Sravani Vekatayogi, et al.
Nature Communications|June 3, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody responseKenta Matsuda, Mitra Harrison, Eleanor Wettstein, et al.
Science Translational Medicine|May 12, 2021
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophagesWillianne Hoepel, Hung-Jen Chen, Chiara E Geyer, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Nature|March 5, 2014
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesNicole A Doria-Rose, Chaim A Schramm, Jason Gorman, et al.
Nature Communications|October 21, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsPauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Nature Communications|November 21, 2025
HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trialEmma I M M Reiss, Karlijn van der Straten, Laura T M Graus, et al.
Cell|February 12, 2021
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionPhilip J M Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2022
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunityLeanne P M van Leeuwen, Corine H GeurtsvanKessel, Pauline M Ellerbroek, et al.
Pageof 92